Shanghai Juncell Therapeutics
Clinical trials sponsored by Shanghai Juncell Therapeutics, explained in plain language.
-
Lung cancer patients' own immune cells may shrink tumors in new trial
Disease control Not yet recruitingThis phase II study tests a treatment made from a patient's own tumor-fighting immune cells (TILs) for non-small cell lung cancer. About 28 adults aged 18-70 whose cancer has not responded to standard treatments will receive their own expanded TILs. The goal is to see if this app…
Phase: PHASE2 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 26, 2026 04:22 UTC
-
Immune cells harvested from tumors could fight cancer in new trial
Disease control Not yet recruitingThis early-stage study tests a therapy made from a patient's own immune cells (called TILs) that are taken from their tumor, multiplied in a lab, and then given back through an IV. The goal is to see if this treatment is safe and can shrink tumors in adults with advanced solid ca…
Phase: PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 26, 2026 04:12 UTC
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Not yet recruitingThis early-stage trial tests an experimental therapy called GC203 TIL, made from a patient's own tumor-fighting immune cells that are multiplied and strengthened in a lab. It is for 8 adults with advanced solid tumors that have not responded to standard treatments. The main goal …
Phase: PHASE1 • Sponsor: Shanghai Juncell Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:52 UTC